Omnicell, Inc. announced that Allegheny General Hospital, part of Allegheny Health Network (AHN), has selected Omnicell’s Central Pharmacy IV Compounding Service for insourcing some sterile compounding operations.
Nearly one out of ten IVs (intravenous therapies) are not prepared within guidelines using manual processes and contamination is one of the most frequent errors. Omnicell’s Central Pharmacy IV Compounding Service addresses this issue with the combination of advanced robotic technology, data and pharmacy technician staff to help hospitals insource their sterile compounding.
“Sterile compounding is one of the biggest challenges for hospital pharmacies. Many hospitals choose to outsource their compounding needs, which can be expensive and unreliable at times. However, moving to an insourcing model requires technology and trained staff,” said Laura Mark, vice president, pharmacy, AHN. “Omnicell’s Central Pharmacy IV Compounding Service provides hospitals the tools and resources they need to insource and automate their sterile compounding, creating a safer, more accurate and, ultimately, more cost-effective IV compounding operation.”
“The Central Pharmacy IV Compounding Service is part of Omnicell’s autonomous pharmacy vision and our pursuit towards 100 percent of IV preparations going through IV automation technology,” said Douglas Descalzi, vice president and general manager, IV Solutions and Robotic Dispensing Systems, Omnicell. “The service enables hospitals to not just automate compounding, but to adopt and optimize the technology.”
